title: Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
authors.forename: P
authors.initials: P
authors.lastname: Fedele
authors.forename: M
authors.initials: M
authors.lastname: Spina
authors.forename: M
authors.initials: M
authors.lastname: Valentini
authors.forename: D
authors.initials: D
authors.lastname: Collini
authors.forename: C
authors.initials: C
authors.lastname: Lucia
authors.forename: M
authors.initials: M
authors.lastname: Manicone
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017829:Granisetron / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017294:Ondansetron / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D017829:Granisetron; D017294:Ondansetron